US Stock MarketDetailed Quotes
JSPRW JASPER THERAPEUTICS INC C/WTS 01/12/2026 (TO PUR COM)
Watchlist
0.0740
+0.0090+13.85% Close 09/25 16:00 ET
0.0745High0.0738Low702Volume
0.0738Open0.0650Pre Close52.00Turnover0.00%Turnover Ratio0.00P/E (TTM)0Market Cap0.253452wk High1.68P/E (Static)0Shares0.016052wk Low0.00P/B0Float Cap2.2400Historical High--Dividend TTM0Shs Float0.0160Historical Low--Div YieldTTM1.08%Amplitude0.0740Avg Price1Lot Size
About JASPER THERAPEUTICS INC C/WTS 01/12/2026 (TO PUR COM) Company
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
Company Profile
SymbolJSPRW
Company NameJASPER THERAPEUTICS INC C/WTS 01/12/2026 (TO PUR COM)
Listing Date01/10/2020
Founded2018
CEOMr. Ronald A. Martell
MarketNASDAQ
Employees35
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2200 Bridge Parkway,Suite 102
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94065
Phone1-650-549-1400
Company Executives
No Data
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--